Sio Gene Therapies Inc. Debt Instrument, Fair Value Disclosure
Sio Gene Therapies Inc. had Debt Instrument, Fair Value Disclosure of $51.40 million as of 2017-03-31, per its 10-K filed 2017-06-13.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2017-06-13
- 2017-03-31: Debt Instrument, Fair Value Disclosure $51.40M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2017-03-31 | $51.40M 10-K · filed 2017-06-13 |